Ranibizumab inhibits multiple forms of biologically active vascular endothelial growth factor in vitro and in vivo
- 1 October 2007
- journal article
- Published by Elsevier BV in Experimental Eye Research
- Vol. 85 (4), 425-430
- https://doi.org/10.1016/j.exer.2007.05.008
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Ranibizumab versus Verteporfin for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006
- Ranibizumab for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006
- Vascular Endothelial Growth Factor: Basic Science and Clinical ProgressEndocrine Reviews, 2004
- Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization.Published by Association for Research in Vision and Ophthalmology (ARVO) ,2003
- Age-Related Macular Degeneration: Etiology, Pathogenesis, and Therapeutic StrategiesSurvey of Ophthalmology, 2003
- Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured fab in complex with antigen 1 1Edited by I. A. WilsonJournal of Molecular Biology, 1999
- Identification and characterization of a new splicing variant of vascular endothelial growth factor: VEGF183Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1998
- VEGF and the Fab fragment of a humanized neutralizing antibody: crystal structure of the complex at 2.4 å resolution and mutational analysis of the interfaceStructure, 1998
- Increased expression of angiogenic growth factors in age-related maculopathyBritish Journal of Ophthalmology, 1997
- Vascular reactions to histamine, histamine‐liberator and leukotaxine in the skin of guinea‐pigsThe Journal of Physiology, 1952